Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jie Qian, Xueyan Zhang, Bo Zhang, Bo Yan, Lin Wang, Ping Gu, Weimin Wang, Huimin Wang & Baohui Han. (2020) Tyrosine Kinase Inhibitor-Related Hepatotoxicity in Patients with Advanced Lung Adenocarcinoma: A Real-World Retrospective Study. Cancer Management and Research 12, pages 3293-3299.
Read now
Read now
Jie Wang, XianYe Cheng, Yan Lu & BingRong Zhou. (2018) A case report of toxic epidermal necrolysis associated with AZD-9291. Drug Design, Development and Therapy 12, pages 2163-2167.
Read now
Read now
Rita Mendes, Bárbara Carreira, Pedro V. Baptista & Alexandra R. Fernandes. (2016) Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnology. Expert Review of Precision Medicine and Drug Development 1:2, pages 155-168.
Read now
Read now
Zhiguo Chen, Wei Xie, Desmond Omane Acheampong, Menghuai Xu, Hua He, Mengqi Yang, Chenchen Li, Chen Luo, Min Wang & Juan Zhang. (2016) A human IgG-like bispecific antibody co-targeting epidermal growth factor receptor and the vascular endothelial growth factor receptor 2 for enhanced antitumor activity. Cancer Biology & Therapy 17:2, pages 139-150.
Read now
Read now
Articles from other publishers (39)
Mu-Chun Li, Mohane Selvaraj Coumar, Shu-Yu Lin, Yih-Shyan Lin, Guan-Lin Huang, Chun-Hwa Chen, Tzu-Wen Lien, Yi-Wen Wu, Yen-Ting Chen, Ching-Ping Chen, Yu-Chen Huang, Kai-Chia Yeh, Chen-Ming Yang, Bikashita Kalita, Shiow-Lin Pan, Tsu-An Hsu, Teng-Kuang Yeh, Chiung-Tong Chen & Hsing-Pang Hsieh. (2023) Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer. Journal of Medicinal Chemistry 66:4, pages 2566-2588.
Crossref
Crossref
Rudradip Das, Gayatri Tambe & Amit Shard. (2023) Sulfonamides as tyrosine kinase modulators – A promising class of anticancer agents. Results in Chemistry 5, pages 100950.
Crossref
Crossref
Xuejian Wang, Wenyan Jiang, Yanmei Du, Dongqi Zhu, Jian Zhang, Chunyan Fang, Fang Yan & Zhe-Sheng Chen. (2022) Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer. Drug Resistance Updates 65, pages 100884.
Crossref
Crossref
Christos Kiritsis, Antonio Shegani, Konstantina Makrypidi, Ioanna Roupa, Aristotelis Lazopoulos, Angeliki Panagiotopoulou, Sotiria Triantopoulou, Maria Paravatou-Petsotas, Hans-Jürgen Pietzsch, Maria Pelecanou, Minas Papadopoulos & Ioannis Pirmettis. (2022) Synthesis and preclinical evaluation of rhenium and technetium-99m “4 + 1” mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents. Bioorganic & Medicinal Chemistry 73, pages 117012.
Crossref
Crossref
Xue Liu, Xin Liu, Mikhail I. Kusaykin, Miansong Zhang, Xinfeng Bai, Tingting Cui, Yaping Shi, Changheng Liu & Airong Jia. (2022) Structural characterization of a P-selectin and EGFR dual-targeting fucoidan from Sargassum fusiforme. International Journal of Biological Macromolecules 199, pages 86-95.
Crossref
Crossref
子繁 王. (2022) Study on First-Generation TKIs in the Treatment of Patients with Unresectable EGFR-Mutation-Positive Non-Small-Cell Lung Cancer. Advances in Clinical Medicine 12:02, pages 761-770.
Crossref
Crossref
Yu-Li Lo, Hua-Ching Lin, Shu-Ting Hong, Chih-Hsien Chang, Chen-Shen Wang & Anya Maan-Yuh Lin. (2021) Lipid polymeric nanoparticles modified with tight junction-modulating peptides promote afatinib delivery across a blood–brain barrier model. Cancer Nanotechnology 12:1.
Crossref
Crossref
Jaya Kala, Liann Abu Salman, Abdallah S. Geara & Hassan Izzedine. (2021) Nephrotoxicity From Molecularly Targeted Chemotherapeutic Agents. Advances in Chronic Kidney Disease 28:5, pages 415-428.e1.
Crossref
Crossref
Vineet K. Gupta, Sulagna Banerjee & Ashok K. Saluja. 2021. Clinical Pancreatology for Practising Gastroenterologists and Surgeons. Clinical Pancreatology for Practising Gastroenterologists and Surgeons
564
572
.
Lyu Weidong, Luca Sanna, Valentina Bordoni, Zeng Tiansheng, Li Chengxun, Gabriele Murineddu, Gerard A. Pinna, David J. Kelvin & Luigi Bagella. (2020) Target identification of a novel unsymmetrical 1,3,4‐oxadiazole derivative with antiproliferative properties. Journal of Cellular Physiology 236:5, pages 3789-3799.
Crossref
Crossref
Saniya Deshmukh & Supreet Saini. (2020) Phenotypic Heterogeneity in Tumor Progression, and Its Possible Role in the Onset of Cancer. Frontiers in Genetics 11.
Crossref
Crossref
Ying Lin, Kazuma Higashisaka, Takuya Shintani, Ayaka Maki, Sachiyo Hanamuro, Yuya Haga, Shinichiro Maeda, Hirofumi Tsujino, Kazuya Nagano, Yasushi Fujio & Yasuo Tsutsumi. (2020) Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells. Scientific Reports 10:1.
Crossref
Crossref
Qizhang Li, Zhiying Wang, Qiang Zheng & Sen Liu. (2020) Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2. Computational and Structural Biotechnology Journal 18, pages 2200-2208.
Crossref
Crossref
Harry A. J. Struijker-Boudier. 2020. Microcirculation in Cardiovascular Diseases. Microcirculation in Cardiovascular Diseases
165
171
.
Lehe Yang, Shichong Lin, Yanting Kang, Youqun Xiang, Lingyuan Xu, Jifa Li, Xuanxuan Dai, Guang Liang, Xiaoying Huang & Chengguang Zhao. (2019) Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Mengya Tong, Mingzhao Gao, Yongping Xu, Li Fu, Yun Li, Xubin Bao, Haoyu Fu, Haitian Quan & Liguang Lou. (2019)
SHR
‐A1403, a novel c‐mesenchymal‐epithelial transition factor (c‐Met) antibody‐drug conjugate, overcomes
AZD
9291 resistance in non‐small cell lung cancer cells overexpressing c‐Met
. Cancer Science 110:11, pages 3584-3594.
Crossref
Crossref
Jing Du, Yuanqiao He, Weiquan Wu, Peng Li, Youwei Chen, Zhiming Hu & Yong Han. (2019)
Targeting EphA2 with miR-124 mediates Erlotinib resistance in
K-RAS
mutated pancreatic cancer
. Journal of Pharmacy and Pharmacology 71:2, pages 196-205.
Crossref
Crossref
Jia Fu, Yanni Lv, Qianqian Jia, Yuanyuan Lin & Shengli Han. (2019) Dual-mixed/CMC model for screening target components from traditional Chinese medicines simultaneously acting on EGFR & FGFR4 receptors. Talanta 192, pages 248-254.
Crossref
Crossref
Kathryn M. Tully, Nicholas B. Sobol, Patrícia M.R. Pereira & Jason S. Lewis. 2019. Companion and Complementary Diagnostics. Companion and Complementary Diagnostics
201
228
.
Tong Wang, Fumou Sun, Yang Wang, Jiahao Jiang, Mingzhu Pan, Minne Yuan, Hang Zhang, Xiaodian Du, Kamal Hezam, Kai Song, Min Wang & Juan Zhang. (2018) NKG2D Immunoligand rG7S-MICA Enhances NK Cell-mediated Immunosurveillance in Colorectal Carcinoma. Journal of Immunotherapy 41:3, pages 109-117.
Crossref
Crossref
Magda F. Mohamed, Hamdi M. Hassaneen & Ismail A. Abdelhamid. (2018) Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones. European Journal of Medicinal Chemistry 143, pages 532-541.
Crossref
Crossref
Elaine R. Mardis. 2018. Principles and Applications of Molecular Diagnostics. Principles and Applications of Molecular Diagnostics
191
200
.
Zhang-Hui Chen, Yan P. Yu, Junyan Tao, Silvia Liu, George Tseng, Michael Nalesnik, Ronald Hamilton, Rohit Bhargava, Joel B. Nelson, Arjun Pennathur, Satdarshan P. Monga, James D. Luketich, George K. Michalopoulos & Jian-Hua Luo. (2017) MAN2A1–FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice. Gastroenterology 153:4, pages 1120-1132.e15.
Crossref
Crossref
Hiroyasu Sakai, Ken Sato, Fumiaki Sato, Yuki Kai, Kazutaka Mandokoro, Kenjiro Matsumoto, Shinichi Kato, Tetsuro Yumoto, Minoru Narita & Yoshihiko Chiba. (2017) Curcumin inhibits epigen and amphiregulin upregulated by 2,4,6-trinitrochlorobenzene associated with attenuation of skin swelling. Inflammation Research 66:8, pages 663-678.
Crossref
Crossref
Hassan Izzedine & Mark A. Perazella. (2017) Adverse kidney effects of epidermal growth factor receptor inhibitors. Nephrology Dialysis Transplantation 32:7, pages 1089-1097.
Crossref
Crossref
Zhiguo Chen, Tong Wang, Xiaojie Tu, Wei Xie, Hua He, Min Wang & Juan Zhang. (2017) Antibody-based targeting of CD24 enhances antitumor effect of cetuximab via attenuating phosphorylation of Src/STAT3. Biomedicine & Pharmacotherapy 90, pages 427-436.
Crossref
Crossref
Stamatios Theocharis, Constantinos Giaginis, Eugene Dana, Irene Thymara, Jose Rodriguez, Efstratios Patsouris & Jerzy Klijanienko. (2017) Phosphorylated Epidermal Growth Factor Receptor Expression Is Associated With Clinicopathologic Parameters and Patient Survival in Mobile Tongue Squamous Cell Carcinoma. Journal of Oral and Maxillofacial Surgery 75:3, pages 632-640.
Crossref
Crossref
R. Ajina, D. AlDeghaither, S. Jablonski & L.M. Weiner. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
32
65
.
Zhen Chen, Yifan Chen, Meng Xu, Likun Chen, Xu Zhang, Kenneth Kin Wah To, Hongyun Zhao, Fang Wang, Zhongjun Xia, Xiaoqin Chen & Liwu Fu. (2016)
Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells
In Vitro, In Vivo
, and
Ex Vivo
. Molecular Cancer Therapeutics 15:8, pages 1845-1858.
Crossref
Crossref
Zhendong Song, Yang Ge, Changyuan Wang, Shanshan Huang, Xiaohong Shu, Kexin Liu, Youwen Zhou & Xiaodong Ma. (2016) Challenges and Perspectives on the Development of Small-Molecule EGFR Inhibitors against T790M-Mediated Resistance in Non-Small-Cell Lung Cancer. Journal of Medicinal Chemistry 59:14, pages 6580-6594.
Crossref
Crossref
Jing-yun Li, Yu-peng Ren, Yin Yuan, Shuang-min Ji, Shu-pei Zhou, Li-jie Wang, Zhen-zhen Mou, Liang Li, Wei Lu & Tian-yan Zhou. (2016) Preclinical PK/PD model for combined administration of erlotinib and sunitinib in the treatment of A549 human NSCLC xenograft mice. Acta Pharmacologica Sinica 37:7, pages 930-940.
Crossref
Crossref
Xiangchao Meng, Baoshan Hu, Mohammad Hossain, Guofu Chen, Ying Sun & Xuepeng Zhang. (2016) ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation. International Journal of Oncology.
Crossref
Crossref
Young‐Joo Jeon, Jin Hyoung Cho, Seung‐Yeop Lee, Yung Hyun Choi, Hongju Park, Seunggon Jung, Jung‐Hyun Shim & Jung‐Il Chae. (2015) Esculetin Induces Apoptosis Through EGFR/PI3K/Akt Signaling Pathway and Nucleophosmin Relocalization. Journal of Cellular Biochemistry 117:5, pages 1210-1221.
Crossref
Crossref
Jun Ni & Li Zhang. (2016) Evaluation of Three Small Molecular Drugs for Targeted Therapy to Treat Nonsmall Cell Lung Cancer. Chinese Medical Journal 129:3, pages 332-340.
Crossref
Crossref
Caifeng Xie, Jiangbo Jin, Xujie Bao, Wei-Hua Zhan, Tian-Yu Han, Mingxi Gan, Chengfu Zhang & Jianbin Wang. (2015) Inhibition of mitochondrial glutaminase activity reverses acquired erlotinib resistance in non-small cell lung cancer. Oncotarget 7:1, pages 610-621.
Crossref
Crossref
Clara Panosa, Humphrey Fonge, Montserrat Ferrer-Batallé, Javier A. Menéndez, Anna Massaguer, Rafael De Llorens & Raymond M. Reilly. (2015) A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111 In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice. Nuclear Medicine and Biology 42:12, pages 931-938.
Crossref
Crossref
Hengyi Chen, Wenxiu Yao, Qian Chu, Rui Han, Yubo Wang, Jianguo Sun, Dong Wang, Yongsheng Wang, Mengshu Cao & Yong He. (2015) Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes. Cancer Letters 369:1, pages 97-102.
Crossref
Crossref
Ningning Cheng, Weijing Cai, Shengxiang Ren, Xuefei Li, Qi Wang, Hui Pan, Mingchuan Zhao, Jiayu Li, Yishi Zhang, Chao Zhao, Xiaoxia Chen, Ke Fei, Caicun Zhou & Fred R. Hirsch. (2015)
Long non-coding RNA
UCA1
induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in
EGFR
-mutant non-small cell lung cancer
. Oncotarget 6:27, pages 23582-23593.
Crossref
Crossref
Shanthi Kanthala, Sandeep Pallerla & Seetharama Jois. (2015) Current and future targeted therapies for non-small-cell lung cancers with aberrant EGF receptors. Future Oncology 11:5, pages 865-878.
Crossref
Crossref